Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.
Checkpoint Therapeutics has raised $12.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2024.
Checkpoint Therapeutics is headquartered in Waltham, United States.
Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.
Checkpoint Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Checkpoint Therapeutics — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/checkpoint-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Checkpoint Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/checkpoint-therapeutics
{{cite web |title=Checkpoint Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/checkpoint-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated